The breadth and depth of IBD research at Mount Sinai is unsurpassed. Our efforts span patient care, new healthcare delivery systems, clinical epidemiology and outcomes, clinical trials, and translational approaches related to genetics, genomics, exposomics, microbiome and immunology. We strongly believe that innovation in IBD arises at the interface of disciplines and through dialogue. So we hope you will take this opportunity to join us and explore new research areas while making personal connections. Expected attendance will be approximately 250 attendees, in-person and virtual.